Exactech, Inc. is having its 20th anniversary of its Nasdaq listing…and they are ringing the Nasdaq bell today. Exactech founders Bill Petty, M.D., Betty Petty and Gary Miller, Ph.D., will ring the Nasdaq Closing Bell on Tuesday, May 3. The ceremony will take place from 3:45 – 4:00 p.m. ET at Nasdaq MarketSite in Times Square, New York.
“We appreciate this opportunity to commemorate 20 years on Nasdaq and to recognize the positive impact our company’s growth has had on employees, surgeon customers and the patients whose lives are improved by our products, ” said Exactech CEO David Petty in the May 2, 2016 news release. “Exactech has always taken a unique approach to the business of orthopaedics. Our purpose of improving outcomes for patients and our unwavering focus on meeting our surgeons’ needs have also yielded solid financial returns for our shareholders. We ring the bell in honor of our past and with eager anticipation of our future.”
As stated in the news release, “At year-end 2015, Exactech reported revenues of $241.8 million and net income of $14.8 million with a market cap of more than $300 million. This year, the company will bring to market three systems to address complex hip, knee and shoulder surgeries in revision arthroplasty, followed by the VantageTM total ankle in 2017. The stock closed Friday April 29th, 2016 at $22.74.”
Asked how they keep innovating, CEO Petty told OTW, “We stay relentlessly focused on engaging with surgeons around whatever that next thing is they just want to do better to improve patient care. Surgeons always want to get better. When we understand how they want to get better, we have demonstrated a competency over time of delivering technological solutions to achieve a specific goal and generally to improve patient outcomes.”
